The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Editor’s Choice

Fecal Microbiota Transplantation (FMT): Global Industry and Regulatory Overview
Editor's Choice

Fecal Microbiota Transplantation (FMT): Global Industry and Regulatory Overview

JUN 27, 2022
Validation of the predictive role of A.muciniphila for response and resistance to PD1 blockade in non small cell lung cancers
Editor's Choice

Validation of the predictive role of A.muciniphila for response and resistance to PD1 blockade in non small cell lung cancers

APR 15, 2022
Did you miss Probiota Copenhagen 2022? Catch up now!
Editor's Choice

Did you miss Probiota Copenhagen 2022? Catch up now!

APR 12, 2022
A new strategy for editing DNA within microbial communities using CRISPR-Cas9 technology
Editor's Choice

A new strategy for editing DNA within microbial communities using CRISPR-Cas9 technology

FEB 18, 2022
Protecting and Preserving the Intestinal Microbiome from Antibiotic-induced Dysbiosis with DAV132
Biotech Showcase

Protecting and Preserving the Intestinal Microbiome from Antibiotic-induced Dysbiosis with DAV132

FEB 17, 2022
ELIGO v SNIPR: a reflection on IP strategies in a competitive environment
Editor's Choice

ELIGO v SNIPR: a reflection on IP strategies in a competitive environment

FEB 7, 2022
Ferring takes pre-emptive action in IP dispute with Finch
Editor's Choice

Ferring takes pre-emptive action in IP dispute with Finch

FEB 2, 2022
Food for Health: A new direction for American Agriculture
Editor's Choice

Food for Health: A new direction for American Agriculture

DEC 14, 2021
CRISPRing the microbiome is just around the corner
Editor's Choice

CRISPRing the microbiome is just around the corner

DEC 10, 2021
Bringing the Transformative Power of Synthetic Biology to Medicine
Biotech Showcase

Bringing the Transformative Power of Synthetic Biology to Medicine

DEC 6, 2021
Eligo Bioscience Announces Successful Outcome in US Patent Interference against SNIPR Biome
Editor's Choice

Eligo Bioscience Announces Successful Outcome in US Patent Interference against SNIPR Biome

DEC 2, 2021